Something hopeful for the New Year....
"The effectiveness of the SA58 Nasal Spray for preventing COVID-19 infection among medical personnel was evaluated as 77.7% (95% CI: 52.2% - 89.6%)."
https://www.medrxiv.org/content/10.1101/2022.12.27.22283698v1
Follow
This reminded me of something I'd read before and a quick search shows that they were supposedly working on something that was called "SA55+SA58" earlier. Way out of my wheelhouse, but I'm wondering if it's just nomenclature or if they moved on from the SA55 component. I'm not sure monoclonal antibodies are the way out of this, but I'll jump on just about any hope bandwagon.
https://www.biorxiv.org/content/10.1101/2022.08.03.499114v1.full
